–Next-generation obesity company with potential best- and first-in-class assets launched by Versant Ventures– –Emerges from stealth with $30 million in Series A financing and a strategic collaboration with AstraZeneca providing up to $80 million– BASEL, Switzerland — SixPeaks Bio AG today emerged from stealth mode with a pipeline of therapies for healthy weight loss, including […] Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
